| 141 - 144 of 144 | Next »
141
Conference item icon
Conference item

AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

  • Arun, T, Sbdarella, E, Ruiter, M, et al.
  • 2012-03-01
142
Journal article icon
Journal article

Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses.

  • Fridkis-Hareli, M, Stern, J, Fugger, L, et al.
  • 2001-08-01
143
Journal article icon
Journal article

Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.

  • Krogsgaard, M, Wucherpfennig, K, Cannella, B, et al.
  • 2000-04-01
144
Journal article icon
Journal article

Deletion of TASK1 and TASK3 channels disrupts intrinsic excitability but does not abolish glucose or pH responses of orexin/hypocretin neurons.

  • González, J, Jensen, LT, Doyle, SE, et al.
  • 2009-07-01
FILTER RESULTS

TO TOP